NEJM Interview: Dr. David Asch on why requiring informed consent for trials that pose minimal risk to participants can do more harm than good.
Oct 11, 2017
10:20
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Dr. David Asch is executive director of the Center for Health Care Innovation at the University of Pennsylvania. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. D.A. Asch, T.A. Ziolek, and S.J. Mehta. Misdirections in Informed Consent - Impediments to Health Care Innovation. N Engl J Med 2017;377:1412-4.
NEJM Interviews